ID   Raji HLA-B*40:01
AC   CVCL_C3D7
DR   cancercelllines; CVCL_C3D7
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312765
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*40:01).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//